Ryan Black

Oscar Insurance, co-founded by Jared Kushner's brother, announced expansion the day before details of GOP health bill emerged.

Two years after the ResearchKit launch, studies using the platform seem to suffer from the same issues it was meant to address.

The company's name will now appear on Withings smart scales and wearables. The devices and the app combine to form an "ecosystem" that Nokia hopes will provide "a 360-degree view of their well-being."

Can drug manufacturers use colossal swaths of data to deliver new pharmaceuticals more efficiently and cost-effectively? And if so, will those savings some day make their way to the patients?

Another week, another IT security threat with a conveniently catchy name: the U.S. Department of Health and Human Services late last week released a warning about a new threat, or series of threats, that could impact healthcare systems.

Experts say that the problem will only get worse, and exponentially so. Still, much can be learned from the recent WannaCry attack.

In the name of an “efficient, risk-based approach” to regulation in order to “promote health” through innovation, Gottlieb detailed a number of initiatives underway or soon to be.

"We are pitting the enthusiasm of the futurists...against the public health perspective that says ‘be careful what you screen for,’” the prominent genomicist says.

The FDA, GINA, and variants of unknown significance all muddy the waters of genomic research and data storage.

Certainly, Walton believes greatly in the potential of genomics to change medicine at its core, but the obstacles preceding that shift are numerous and substantial, he argued.

"It truly can transform how we diagnose and treat cancer patients. They've just never had these kinds of tools before," says the Hackensack Meridian Health co-CEO.

Cerner Corp. nailed down a $4 billion-plus Department of Defense contract in 2015. The deal with the VA bypassed the typical public bidding process.

Trio will pilot program to leverage Watson's computational power to determine value-based treatment options for cancer patients.

Data scientists and clinical researchers collaborate on MiSL, or “Mining Synthetic Lethals,” to identify genetic duos within tumors that allow cancer to survive.

Of all of the conditions that technological innovation has the potential to mitigate, assuage, and aid, vision loss leaves plenty of room for the novel and life-changing.

"My particular joy is in innovation, and trying to innovate before the problem occurs, before the pain is really felt, and having a solution ready for when it does hit," Suit says.

In the second part of an interview with CMO Daniel Lace, the doctor turned the conversation to how he defines value-based care.

The CMO of Leaders in Medicine sat down with Healthcare Analytics News for a ranging interview focused on value-based care and innovation.

Recent reports of a new team at the FDA that will try to match healthtech's pace of innovation mesh with previous writings by the Administration's recently-appointed head, Scott Gottlieb.

When it was a mere "online bookseller," Amazon invested in 40% of an online pharmacy that didn't quite pan out. Now the preeminint online retail giant, the company is believed to be taking another look at the complex industry.

electroCore's device provides mild electrical stimulation to the vagus nerve in order to alleviate headaches.

The Project ECHO programs in New Mexico seek to use mass specialist-to-primary teleconferencing to improve treatment of conditions like diabetes across a vast, rural state.

Equipped with the pancreas and a Fitbit, the children successfully maintained good blood sugar levels despite elevated activity.

A House of Representitives vote on the American Health Care Act did not fall on the seventh anniversary of the signing of the Affordable Care Act. Now it will not occur at all.

In the second part of our interview with CCHP director Gutierrez, he speaks about how telehealth policy is evolving nationwide.

"We have to change that dynamic and think about the consumer at the center of the healthcare system," Mario Gutierrez says.

A wide reach and vast accesibility allowed the researchers to see nationwide data and detect trends, but the program suffered from the same natural enthusiasm decay that any mobile app does.

"It’s a constant theme we'll be talking about continuously," Hart says. "Patients are saying "we need this support" and yet very few providers are delivering it. "

New Enterprise Associates boasts a portfolio with more than an alphabet's worth of drug makers and research firms in the fold. It also might boast the new head of the Food and Drug Administration.

In the final interview installment, David Engelhardt of ReadyDock Inc., speaks of how the company’s collaboration with Samsung can clean a device of bacteria and data alike.